Hints and tips:
Related Special Reports
...Earlier this month, UK chancellor Jeremy Hunt announced Canary Wharf Group would receive a £118mn loan from a government housing infrastructure fund to support developing a life-sciences centre, a healthcare...
...Merck, a healthcare to life sciences group, submitted a takeover offer for JSR in the autumn of 2022, according to the four people familiar with the situation....
...Several early-stage life sciences investors told the Financial Times the technology was attractive but that the field faced a higher bar for investment than other start-ups....
...Other companies: KKR, Spotify, GE Healthcare, and Hertz are also reporting before the bell. Amgen, Gilead Sciences, Chipotle, Ford and Snap are reporting after the bell....
...In 2012, Clark and his cousin Galahad founded Vivobarefoot, a footwear brand (certified B Corp) developing design solutions to tackle these issues....
...Last week, the Danish drugmaker also entered a partnership with GE Healthcare to develop new ways of tackling obesity and diabetes using ultrasound technology....
...The problems of overreliance on broad spectrum antibiotics and a lack of diagnosis are likely to persist in regions without state of the art healthcare, and the resulting resistant superbugs are unlikely...
...life — in the first two years post-infection, compared with 50 for cancer and 52 for heart disease, according to researchers at Washington University School of Medicine and the Veterans Affairs St Louis healthcare...
...British drugmaker GSK also spent $1.4bn on Anglo-American biotech Aiolos Bio to restock its respiratory pipeline. Merck and medical device maker Boston Scientific also announced acquisitions....
...Here’s what else I’m keeping tabs on today: Results: Eli Lilly, the maker of weight loss drug Mounjaro, reports this morning alongside KKR, Spotify, GE Healthcare and Hertz....
...Months earlier Merck, a German healthcare and life sciences group, had proposed buying a majority stake in the Japanese company, according to two people with knowledge of its content....
...Currently, the US receives 68 per cent of global biotech investment, according to the industry group Bio, and half of the top 20 biggest spenders on pharma research and development last year were American...
...says in a worst-case scenario, antimicrobial resistance could reduce annual global gross domestic product by 3.8 per cent by 2050, push an additional 28mn people into extreme poverty, and increase global healthcare...
...The Covid-19 pandemic put life sciences under a spotlight, accelerating a growing interest in healthcare that was already under way among family offices, says Nooman Haque, a life sciences investor based...
...“It’s a big turnround and completely bucking the overall trend in the M&A market,” said Tim Opler, managing director at Stifel’s global healthcare group....
...But the FT reported that months earlier, Merck, a German healthcare and life sciences group, had proposed buying a majority stake in the Japanese company....
...Letter in response to this article: Healthcare must embrace gene therapy to catch up with science / From Timothy D Hunt, Chief Executive, Alliance for Regenerative Medicine, Washington, DC, US...
...Jon Williams, Viridi’s chief executive and a Buffalo native, pays his employees $18 an hour, with healthcare, stock options and a retirement plan included....
...Susan Lee, a partner at the law firm Goodwin who specialises in life sciences regulation, said Kacsmaryk had several options when issuing his ruling....
...“provides comfort for small innovative companies like mine . . . creating jobs, developing new medicines and improving healthcare for patients”....
...Prime minister Rishi Sunak has charged science minister George Freeman with developing an alternative British plan....
...The stocks of vaccine makers China National Medicines Corp, CanSino Biologics and Walvax Biotechnology remained flat....
...He said while R&D investment decisions are driven by a country’s science base, pricing policy does affect overall investment....
...The Elliott Management investor behind activist campaigns at UK healthcare giant GSK and Germany’s Fresenius has left the £55.7bn hedge fund, adding to an exodus of senior figures in its London office....
...Quaint bios (“tea enthusiast”). Cultural references to the science-fiction or superhero genres. Self-mockery about bad dates and social awkwardness....
International Edition